Expert Interview
A prescriber check-in on AbbVie's Vyalev (foscarbidopa + foslevodopa) for Advanced Parkinson's Disease
Ticker(s): ABBV, SUPN, MSBHFInstitution: Neurology Center of Nevada
- Board certified and fellowship trained Movement Disorders Neurologist.
- Manages over 2,000 Parkinson's Disease patients monthly
- Specializes in the diagnosis and management of Parkinson's Disease, atypicalparkinsonism (PSP, MSA, DLB), essential tremor, dystonia, myoclonus, ataxia, chorea,tardive syndromes, restless leg syndrome, tourette's/tic disorders. Expertly trained in Deep Brain Stimulation (DBS) programming and botulinum toxin (botox) injections for migraine, dystonia, andspasticity.
Describe your background and practice setting
What is your standard of care for Parkinson's Disease?
Added By: ben_adminHow many patients have you prescribed Vyalev?
Added By: ben_adminWho is the ideal patient for Vyalev?
How has the use of Vyalev changed your management of advanced PD patients?
Added By: ben_adminRank your excitement for Vyalev on a scale of 1-10?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
